Summary for Clinical Practice
Oral mucositis (chemoradiation)
Strong — use is recommended
MASCC/ISOO, NICE[11][12]
Low back pain
Recommended
American College of Physicians[^12]
Fibromyalgia
Moderate evidence, consider as adjunct
Multiple meta-analyses[^11]
Knee osteoarthritis
Moderate evidence for disability reduction
Multiple meta-analyses[^11]
Burning mouth syndrome
Moderate evidence for pain
Meta-analysis[^11]
Androgenetic alopecia
Moderate evidence, FDA-cleared
Meta-analysis[11][3]
Wound healing / Diabetic ulcers
Promising; low-moderate certainty
Systematic reviews[11][15]
Neurological conditions (TBI, PD)
Experimental; further trials needed
University of Utah, 2025[^17]
Key clinical takeaway: PBM and LED-based photobiomodulation therapy have a well-established safety record, a credible mechanistic basis, and meaningful clinical efficacy across a growing number of indications — with the strongest evidence in oral/orofacial and musculoskeletal domains. Standardization of protocols and additional high-quality multicenter RCTs remain the field's primary research priority.